BUCCAL DOSAGE FORMS COMPRISING OLIGOSACCHARIDES

The present application relates to buccal dosage forms comprising one or more cannabinoids and/or cannabinoid extracts and one or more oligosaccharides such as fructo- oligosaccharide alone or in combination with one or more polysaccharides such as inulin, and optionally including a plasticizer such...

Full description

Saved in:
Bibliographic Details
Main Authors ZHOU, QINGRU, HARQUAIL, JASON MATHIEU, DOIRON, JEREMIE ADRIEN
Format Patent
LanguageEnglish
French
Published 26.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present application relates to buccal dosage forms comprising one or more cannabinoids and/or cannabinoid extracts and one or more oligosaccharides such as fructo- oligosaccharide alone or in combination with one or more polysaccharides such as inulin, and optionally including a plasticizer such as glycerin. The present application also related to buccal dosage forms comprising one or more polysaccharides such as inulin and a plasticizer. The buccal dosage forms include hard molded lozenges, soft chew lozenges, and compressed tablets. The one or more cannabinoids and/or cannabinoid extracts include cannabidiol (CBD) and tetrahydrocannabinol (THC). The present application also relates to buccal dosage forms which are free from added sugars, sweeteners and/or sweetening agents. Methods of preparing the buccal dosage forms are also included. La présente demande concerne des formes galéniques buccales comprenant un ou plusieurs cannabinoïdes et/ou extraits de cannabinoïdes et un ou plusieurs oligosaccharides tels quun fructo-oligosaccharide seul ou en association avec un ou plusieurs polysaccharides tels que linuline, et comprenant éventuellement un plastifiant tel que la glycérine. La présente demande concerne également des formes galéniques buccales comprenant un ou plusieurs polysaccharides tels que linuline et un plastifiant. Les formes galéniques buccales incluent les pastilles moulées dures, les pastilles à mâcher molles et les comprimés compressés. Le ou les cannabinoïdes et/ou extraits de cannabinoïdes incluent le cannabidiol (CBD) et le tétrahydrocannabinol (THC). La présente demande concerne également des formes galéniques buccales qui sont sans sucre ajouté, édulcorants et/ou agents édulcorants. Des procédés de préparation des formes galéniques buccales sont également compris.
AbstractList The present application relates to buccal dosage forms comprising one or more cannabinoids and/or cannabinoid extracts and one or more oligosaccharides such as fructo- oligosaccharide alone or in combination with one or more polysaccharides such as inulin, and optionally including a plasticizer such as glycerin. The present application also related to buccal dosage forms comprising one or more polysaccharides such as inulin and a plasticizer. The buccal dosage forms include hard molded lozenges, soft chew lozenges, and compressed tablets. The one or more cannabinoids and/or cannabinoid extracts include cannabidiol (CBD) and tetrahydrocannabinol (THC). The present application also relates to buccal dosage forms which are free from added sugars, sweeteners and/or sweetening agents. Methods of preparing the buccal dosage forms are also included. La présente demande concerne des formes galéniques buccales comprenant un ou plusieurs cannabinoïdes et/ou extraits de cannabinoïdes et un ou plusieurs oligosaccharides tels quun fructo-oligosaccharide seul ou en association avec un ou plusieurs polysaccharides tels que linuline, et comprenant éventuellement un plastifiant tel que la glycérine. La présente demande concerne également des formes galéniques buccales comprenant un ou plusieurs polysaccharides tels que linuline et un plastifiant. Les formes galéniques buccales incluent les pastilles moulées dures, les pastilles à mâcher molles et les comprimés compressés. Le ou les cannabinoïdes et/ou extraits de cannabinoïdes incluent le cannabidiol (CBD) et le tétrahydrocannabinol (THC). La présente demande concerne également des formes galéniques buccales qui sont sans sucre ajouté, édulcorants et/ou agents édulcorants. Des procédés de préparation des formes galéniques buccales sont également compris.
Author ZHOU, QINGRU
HARQUAIL, JASON MATHIEU
DOIRON, JEREMIE ADRIEN
Author_xml – fullname: ZHOU, QINGRU
– fullname: HARQUAIL, JASON MATHIEU
– fullname: DOIRON, JEREMIE ADRIEN
BookMark eNrjYmDJy89L5WTQdwp1dnb0UXDxD3Z0d1Vw8w_yDVZw9vcNCPIM9vRzV_D38XQHSjk7ezgGebq4BvMwsKYl5hSn8kJpbgZ5N9cQZw_d1IL8-NTigsTk1LzUknhnR2NDIwszSzNnY8IqAGOiJvM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORMES DE DOSAGE BUCCAL COMPRENANT DES OLIGOSIDES
ExternalDocumentID CA3128696C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA3128696C3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:01:22 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA3128696C3
Notes Application Number: CA20213128696
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230926&DB=EPODOC&CC=CA&NR=3128696C
ParticipantIDs epo_espacenet_CA3128696C
PublicationCentury 2000
PublicationDate 20230926
PublicationDateYYYYMMDD 2023-09-26
PublicationDate_xml – month: 09
  year: 2023
  text: 20230926
  day: 26
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies ORGANIGRAM INC
RelatedCompanies_xml – name: ORGANIGRAM INC
Score 3.4912124
Snippet The present application relates to buccal dosage forms comprising one or more cannabinoids and/or cannabinoid extracts and one or more oligosaccharides such as...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title BUCCAL DOSAGE FORMS COMPRISING OLIGOSACCHARIDES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230926&DB=EPODOC&locale=&CC=CA&NR=3128696C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANBmi8e0C9VRN9ZM2hQl3SrkXrQ-1Au01t1wouY2JF_H2cqgUuu0WJ5CSWvnx24tgAD0hKVaZlpqIbGVX0sqAK0hBRHstxVmgrZJQmmjAIifeiPy-MRQ_eur8wTZ7Q7yY5IiKqQLzXzXm9-bvE4k1s5XaUv2PXx5M7t7jcesdoT1OVyHxiOXHEIyYzZjFbDhNLw3OYUML2YF8Y0SLLvvM6EX9SNv8JxT2BgxhlretT6JXrARyxru7aAA6D9rkbmy3ytmcwQmOS2TOJR-INSELfLUglFgVx4qd-OJWimT_FIcY8O_G5k57DvevMmafgzMvfTS6Z3S1Ru4A-uv7lECRVJEMvKlqZK02UKaf5uCRmlhd6biA49UsY7pJytXvoGo6FqkTUg0puoF9_fpW3SK11ftdo5QfUFnh8
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQIwbDNB4rgfUWzXRR9YcKtSl3VroS21Bu1Vt12pcxsSK-Ps41QZcdosSyUksffnsxLEBHpCU6lzJdUnVciqpVUklpCEiPVbjvFQWyChtNKEfEOdVfZ5r8w4sd39h2jyh321yRERUiXhv2vN6_XeJZbWxlZtR8Y5dH0_T1LDErXeM9jSViWhNDDsKrZCJjBnMFIPYUPAcJpSwAzgc89y83HB6m_A_Kev_hDI9haMIZa2aM-hUqz702K7uWh-O_e1zNza3yNucwwiNSWZ6ghXyNyABfTc_EVjoR7GbuMFMCD13hkOMOWbsWnZyAcOpnTJHwpmz301mzNwtUbmELrr-1QAEmSdDL2ta6wuFlymnxbgiel6UaqEhONUrGOyTcr1_aAg9J_W9zHODlxs44WrjERAyuYVu8_lV3SHNNsV9q6Efnjd7aQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BUCCAL+DOSAGE+FORMS+COMPRISING+OLIGOSACCHARIDES&rft.inventor=ZHOU%2C+QINGRU&rft.inventor=HARQUAIL%2C+JASON+MATHIEU&rft.inventor=DOIRON%2C+JEREMIE+ADRIEN&rft.date=2023-09-26&rft.externalDBID=C&rft.externalDocID=CA3128696C